PNC Financial Services Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.2M | Buy |
1,387,652
+228,028
| +20% | +$12.4M | 0.03% | 289 |
|
|
2026
Q1 | $72.8M | Sell |
1,159,624
-28,392
| -2% | -$2.27M | 0.04% | 240 |
|
|
2025
Q4 | $113M | Sell |
1,188,016
-33,827
| -3% | -$3.32M | 0.06% | 182 |
|
|
2025
Q3 | $119M | Buy |
1,221,843
+6,047
| +0.5% | +$626K | 0.07% | 175 |
|
|
2025
Q2 | $131M | Buy |
1,215,796
+63,237
| +5% | +$6.4M | 0.08% | 152 |
|
|
2025
Q1 | $116M | Buy |
1,152,559
+32,087
| +3% | +$3.23M | 0.06% | 161 |
|
|
2024
Q4 | $100M | Sell |
1,120,472
-224,145
| -17% | -$19.7M | 0.07% | 175 |
|
|
2024
Q3 | $113M | Buy |
1,344,617
+83,431
| +7% | +$6.58M | 0.07% | 167 |
|
|
2024
Q2 | $97.1M | Sell |
1,261,186
-13,002
| -1% | -$952K | 0.06% | 178 |
|
|
2024
Q1 | $87.3M | Buy |
1,274,188
+86,496
| +7% | +$5.56M | 0.06% | 190 |
|
|
2023
Q4 | $68.7M | Buy |
1,187,692
+66,166
| +6% | +$3.53M | 0.05% | 217 |
|
|
2023
Q3 | $59.2M | Buy |
1,121,526
+939,307
| +515% | +$49.3M | 0.05% | 221 |
|
|
2023
Q2 | $9.86M | Buy |
182,219
+82,715
| +83% | +$4.32M | 0.01% | 493 |
|
|
2023
Q1 | $4.98M | Buy |
99,504
+11,209
| +13% | +$528K | ﹤0.01% | 637 |
|
|
2022
Q4 | $4.09M | Buy |
88,295
+4,986
| +6% | +$216K | ﹤0.01% | 679 |
|
|
2022
Q3 | $3.23M | Buy |
83,309
+12,262
| +17% | +$492K | ﹤0.01% | 720 |
|
|
2022
Q2 | $2.65M | Buy |
71,047
+3,394
| +5% | +$138K | ﹤0.01% | 795 |
|
|
2022
Q1 | $3M | Buy |
67,653
+3,072
| +5% | +$133K | ﹤0.01% | 816 |
|
|
2021
Q4 | $2.74M | Sell |
64,581
-2,620
| -4% | -$110K | ﹤0.01% | 862 |
|
|
2021
Q3 | $2.92M | Buy |
67,201
+2,288
| +4% | +$101K | ﹤0.01% | 797 |
|
|
2021
Q2 | $2.78M | Sell |
64,913
-549
| -0.8% | -$23.1K | ﹤0.01% | 815 |
|
|
2021
Q1 | $2.53M | Sell |
65,462
-2,128
| -3% | -$80.5K | ﹤0.01% | 804 |
|
|
2020
Q4 | $2.43M | Sell |
67,590
-2,726
| -4% | -$98.3K | ﹤0.01% | 786 |
|
|
2020
Q3 | $2.69M | Buy |
70,316
+1,576
| +2% | +$60.7K | ﹤0.01% | 726 |
|
|
2020
Q2 | $2.41M | Sell |
68,740
-6,928
| -9% | -$249K | ﹤0.01% | 737 |
|
|
2020
Q1 | $2.47M | Sell |
75,668
-3,790
| -5% | -$148K | ﹤0.01% | 693 |
|
|
2019
Q4 | $3.59M | Buy |
79,458
+1,632
| +2% | +$68.3K | ﹤0.01% | 669 |
|
|
2019
Q3 | $3.17M | Buy |
77,826
+7,710
| +11% | +$327K | ﹤0.01% | 803 |
|
|
2019
Q2 | $3.02M | Sell |
70,116
-917
| -1% | -$35.3K | ﹤0.01% | 864 |
|
|
2019
Q1 | $2.72M | Buy |
71,033
+5,030
| +8% | +$192K | ﹤0.01% | 922 |
|
|
2018
Q4 | $2.33M | Sell |
66,003
-2,657
| -4% | -$96.4K | ﹤0.01% | 943 |
|
|
2018
Q3 | $2.64M | Buy |
68,660
+9,003
| +15% | +$314K | ﹤0.01% | 975 |
|
|
2018
Q2 | $1.95M | Sell |
59,657
-2,255
| -4% | -$68K | ﹤0.01% | 1054 |
|
|
2018
Q1 | $1.69M | Sell |
61,912
-16,389
| -21% | -$445K | ﹤0.01% | 1094 |
|
|
2017
Q4 | $1.94M | Sell |
78,301
-4,179
| -5% | -$115K | ﹤0.01% | 1047 |
|
|
2017
Q3 | $2.41M | Buy |
82,480
+14,061
| +21% | +$388K | ﹤0.01% | 959 |
|
|
2017
Q2 | $1.9M | Buy |
68,419
+3,912
| +6% | +$104K | ﹤0.01% | 1020 |
|
|
2017
Q1 | $1.6M | Buy |
64,507
+6,767
| +12% | +$165K | ﹤0.01% | 1099 |
|
|
2016
Q4 | $1.25M | Sell |
57,740
-604
| -1% | -$13.2K | ﹤0.01% | 1180 |
|
|
2016
Q3 | $1.39M | Sell |
58,344
-17,474
| -23% | -$417K | ﹤0.01% | 1140 |
|
|
2016
Q2 | $1.77M | Buy |
75,818
+1,883
| +3% | +$40.7K | ﹤0.01% | 997 |
|
|
2016
Q1 | $1.39M | Buy |
73,935
+16,433
| +29% | +$289K | ﹤0.01% | 1110 |
|
|
2015
Q4 | $1.06M | Buy |
57,502
+3,945
| +7% | +$70.7K | ﹤0.01% | 1188 |
|
|
2015
Q3 | $878K | Sell |
53,557
-693
| -1% | -$11.8K | ﹤0.01% | 1275 |
|
|
2015
Q2 | $961K | Sell |
54,250
-659
| -1% | -$11.8K | ﹤0.01% | 1290 |
|
|
2015
Q1 | $974K | Buy |
54,909
+5,548
| +11% | +$87.7K | ﹤0.01% | 1272 |
|
|
2014
Q4 | $653K | Sell |
49,361
-799
| -2% | -$10.2K | ﹤0.01% | 1403 |
|
|
2014
Q3 | $592K | Sell |
50,160
-1,681
| -3% | -$21.2K | ﹤0.01% | 1379 |
|
|
2014
Q2 | $661K | Sell |
51,841
-1,291
| -2% | -$16.8K | ﹤0.01% | 1276 |
|
|
2014
Q1 | $718K | Buy |
53,132
+1,863
| +4% | +$24.5K | ﹤0.01% | 1205 |
|
|
2013
Q4 | $616K | Sell |
51,269
-23,641
| -32% | -$279K | ﹤0.01% | 1255 |
|
|
2013
Q3 | $878K | Buy |
74,910
+1,808
| +2% | +$19.6K | ﹤0.01% | 1060 |
|
|
2013
Q2 | $676K | Buy |
+73,102
| New | +$620K | ﹤0.01% | 1145 |
|
Other funds holding BSX
PNC Financial Services Group's BSX Position: Q2 2026 in Review
PNC Financial Services Group increased its Boston Scientific (BSX) stake by 20% in Q2 2026, buying an estimated $12.4M and bringing the position to 1,387,652 shares worth $59.2M. The position accounts for 0.03% of the portfolio, ranked #289.
PNC Financial Services Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $131M in Q2 2025. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- PNC Financial Services Group held 1,387,652 shares of Boston Scientific worth $59.2M as of Q2 2026.
- PNC Financial Services Group bought 228,028 Boston Scientific shares in Q2 2026, an estimated $12.4M.
- Boston Scientific made up 0.03% of PNC Financial Services Group's portfolio in Q2 2026, its #289 holding.
- PNC Financial Services Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- PNC Financial Services Group's Boston Scientific position peaked at $131M in Q2 2025.
- 1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.